UM Ventures

The page covers new technologies and events at UM Ventures.

The featured article covers the achievements of UMB student entrepreneurs, with insights from Linda Petrillo, PhD, a research and alliance officer at University of Maryland, Baltimore.

Protaryx Medical, a medical device company developing access solutions for minimally invasive left-heart procedures, announced that it received 510(k) clearance.

RA Capital's Series A financing supports Secretome Therapeutics' neonatal cardiac progenitor cell platform and planned Phase 2 and Phase 3 trials of STM-01 in Duchenne muscular dystrophy-associated cardiomyopathy. David Lubner joined its board.

UM Ventures is a joint initiative of the MPowering the State Program, bringing the University of Maryland, Baltimore and College Park together.

The UM Ventures initiative includes several programs that are shaped to advance technology development and new venture creation.

The page lists UM Ventures' partnership companies.

UM Ventures has seen strong increases in technology transfer results.

UM Ventures is a team of professionals with expertise in all aspects of technology transfer.

UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.